Quantcast

Latest TNI BioTech Inc. Stories

2014-09-29 16:25:44

ORLANDO, Fla. and DUBLIN, Sept. 29, 2014 /PRNewswire/ -- TNI BioTech, Inc. (OTC-BB: TNIB) ("we" or the "Company"), a biotechnology company pioneering the manufacturing both US and Internationally as well as the marketing of innovative therapies for cancer, HIV/AIDS, opportunistic infections and autoimmune diseases in emerging nations, issued a letter to its shareholders from CEO Noreen Griffin The letter follows: Dear Shareholders, TNI BioTech, Inc. (the "Company" or "TNIB")...

2014-09-23 16:27:26

ORLANDO, Fla. and DUBLIN, Sept. 23, 2014 /PRNewswire/ --TNI BioTech, Inc. (OTC-BB: TNIB) ("we" or the "Company"), a biotechnology company pioneering the manufacturing and marketing of innovative therapies for autoimmune diseases in emerging nations, today announced that the Depository Trust Company ("DTC") has approved our common stock for DTC's Deposit and Withdrawal at Custodian ("DWAC") service using a Fast Automated Securities Transfer Service ("FAST") transfer agent as the...

2014-09-09 08:30:24

ORLANDO, Fla. and DUBLIN, Sept. 9, 2014 /PRNewswire/ -- TNI BioTech, Inc. (OTC-BB: TNIB) ("we" or the "Company"), a biotechnology company pioneering the manufacturing and marketing of innovative therapies for autoimmune diseases in emerging nations, today announced the results of its 2014 annual general meeting of shareholders. The shareholders of the Company have approved all the matters submitted to them at the Company's 2014 annual general meeting held at 10:00 a.m., Eastern...

2014-08-27 08:27:25

ORLANDO, Fla, Aug. 27, 2014 /PRNewswire/ -- TNI BioTech Inc. (OTCQB: TNIB), ("we" or the "Company") a biotechnology company pioneering the manufacturing and marketing of innovative therapies for autoimmune diseases in emerging nations, today announced it had received payment and will make its first shipments of Lodonal(®) to the Republic of Panama and The Republic of Malawi in conjunction with our marketing partner, The Brewer Group, Inc. Commenting on the initial shipments, Noreen...

2014-08-18 12:27:20

ORLANDO, Fla., Aug. 18, 2014 /PRNewswire/ -- TNI BioTech, Inc. (OTC-BB: TNIB) ("we" or the "Company") a biotechnology company pioneering the manufacturing and marketing of innovative therapies for autoimmune diseases in emerging nations, announced today that the Company is providing a second notice of TNI BioTech's annual meeting of September 4, 2014. In making the announcement, Noreen Griffin, founder and CEO of TNI BioTech Inc. said, "Thank you in advance for your participation in...

2014-08-14 16:26:23

ORLANDO, Fla., Aug. 14, 2014 /PRNewswire/ -- TNI BioTech, Inc. (OTC-BB: TNIB) ("we" or the "Company") a biotechnology company pioneering the manufacturing and marketing of innovative therapies for autoimmune diseases in emerging nations, announced today that the Company is extending the record date of the dividend of Cytocom Inc., shares to all shareholders of the Company to September 30th, 2014. The Company will pay out a dividend of one share of Cytocom Inc. for one share of the Company....

2014-08-13 08:29:09

New Drug Development Efforts for Novel Cancer Treatments ORLANDO, Fla. and HUBEI, China, Aug. 13, 2014 /PRNewswire/ -- TNI BioTech, Inc. (OTC: TNIB) ("TNI" or the "Company") a biotechnology company pioneering the manufacturing and marketing of innovative therapies for autoimmune diseases in emerging nations, announced today the signing of a supplemental agreement with Hubei Qianjiang Pharmaceutical Co., Ltd (SHSE:600568) ( Qianjiang) China on behalf of Cytocom, TNI BioTech's wholly owed...

2014-07-14 16:24:17

- TNIB extends record date pursuant to a demand by shareholders. ORLANDO, Fla., July 14, 2014 /PRNewswire/ -- TNI BioTech, Inc. - (OTCQB: TNIB) ("TNIB" or the "Company"), a biotechnology company focused on developing innovative, targeted immune therapies, today announced that its Board of Directors has extended the record date of our spin-off of Cytocom, Inc., a subsidiary of TNIB. The Company's Board received a Letter on July 13, 2014 from Carricklee Consulting Ltd on behalf of...

2014-06-25 12:30:20

ORLANDO, Fla. and DUBLIN, June 25, 2014 /PRNewswire/ -- TNI BioTech, Inc. (OTC-TNIB) ("TNI BioTech") earlier today announced that its pharmaceutical sales division, Airmed Biopharma Limited, ("Airmed"), a wholly owned Irish Company, has signed a non-exclusive distribution agreement with PanAm Global Logistics, Inc. ("PanAm") to market Lodonal(TM). In the press release, TNI BioTech and Airmed reported receipt of an initial purchase order for $150,000 and that by the agreement, PanAm...

2014-06-25 08:31:51

ORLANDO, Fla. and DUBLIN, June 25, 2014 /PRNewswire/ -- TNI BioTech, Inc. (OTC-TNIB) ("TNI BioTech") is pleased to announce that its pharmaceutical sales division, Airmed Biopharma Limited, ("Airmed"), a wholly owned Irish Company, has signed a non-exclusive distribution agreement with PanAm Global Logistics, Inc. ("PanAm") to market Lodonal(TM). TNI BioTech had received approval for Lodonal(TM) from the Republic of Malawi and with that approval Airmed has signed a distribution...


Word of the Day
cacodemon
  • An evil spirit; a devil.
  • A nightmare.
  • In astrology, the twelfth house of a scheme or figure of the heavens: so called from its signifying dreadful things, such as secret enemies, great losses, imprisonment, etc.
'Cacodemon' comes from a Greek term meaning 'evil genius.'
Related